Cargando…
Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes
A sigma-2 receptor agonist siramesine has been shown to trigger cell death of cancer cells and to exhibit a potent anticancer activity in vivo. However, its mechanism of action is still poorly understood. We show that siramesine can induce rapid cell death in a number of cell lines at concentrations...
Autores principales: | Hafner Česen, M, Repnik, U, Turk, V, Turk, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824671/ https://www.ncbi.nlm.nih.gov/pubmed/24091661 http://dx.doi.org/10.1038/cddis.2013.361 |
Ejemplares similares
-
Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo
por: Jensen, Stine S., et al.
Publicado: (2017) -
Acute effects of the sigma-2 receptor agonist siramesine on lysosomal and extra-lysosomal proteolytic systems in lens epithelial cells
por: Jonhede, S., et al.
Publicado: (2010) -
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells
por: Ma, S, et al.
Publicado: (2016) -
Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells
por: Ma, Shumei, et al.
Publicado: (2017) -
BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomes
por: Rigo, Antonella, et al.
Publicado: (2019)